Literature DB >> 9409179

Circadian pattern of post-surgical fatal pulmonary embolism.

G Belcaro1, A N Nicolaides, G Geroulakos, L Artese, G Laurora, M R Cesarone, M T de Sanctis, L Incandela, A Ricci, G Ramaswami, L Willows.   

Abstract

BACKGROUND: The circadian distribution of fatal pulmonary thromboembolism in general surgical patients is unknown. PATIENTS AND METHODS: One hundred consecutive cases of pulmonary embolism, with reliable clinical notes and data, were studied (67 men and 33 women; mean age 71 years). Only post-surgical cases were considered in this analysis. Patients had undergone elective (78%) or emergency abdominal surgery (22%). Correct prophylaxis (according to the Windsor Consensus Statement) had been used in 12%. Cases were grouped according to the time of onset of signs and symptoms related to pulmonary embolism at one hour intervals.
RESULTS: The maximum incidence of fatal pulmonary embolism was between 7.00 a. m. and 1.00 p. m. with the highest peaks at 9.00 and 11.00 a. m. 9% of deaths) (P < 0.02). When results from this study were compared to a previous study no significant difference was observed between the distribution profile of cases from general medical wards and surgical wards.
CONCLUSION: It appears that in surgical patients there is a circadian pattern in pulmonary embolism as already documented in medical patients.

Entities:  

Mesh:

Year:  1997        PMID: 9409179

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  2 in total

Review 1.  Actigraphy for measurement of sleep and sleep-wake rhythms in relation to surgery.

Authors:  Michael T Madsen; Jacob Rosenberg; Ismail Gögenur
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

2.  Disturbances in the circadian pattern of activity and sleep after laparoscopic versus open abdominal surgery.

Authors:  Ismail Gögenur; Thue Bisgaard; Stefan Burgdorf; Eus van Someren; Jacob Rosenberg
Journal:  Surg Endosc       Date:  2008-10-02       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.